Innovia To Report Fourth Quarter And Full Year 2016 Financial Results On February 9, 2017 At 5:00 P.M. EST Post author:Sam Post published:February 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bay Area's Adamas Pharma Pays Big Bucks to Double HQ January 21, 2018 AstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer May 7, 2017 <b>Janpix</b> Launches With $22 Million and Will be Helmed by Ex-Boehringer Ingelheim Exec October 10, 2017
AstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer May 7, 2017
<b>Janpix</b> Launches With $22 Million and Will be Helmed by Ex-Boehringer Ingelheim Exec October 10, 2017